SOLUTION / PUBLIC SOURCE RECORD
Geno breeding for cattle health and fertility
- Published March 22, 2023; updated September 21, 2026; estimated reading time 2 minutes. Status: available. Markets listed: Americas, Europe and Asia. Industry: Agritech and food production.
- Geno supplies Norwegian Red cattle genetics and dairy-bull semen for breeding and crossbreeding. Its breeding programme emphasizes health and fertility, and the page describes its goal as improving animal welfare, reducing antibiotic use and supporting sustainable dairy production.
- A national registry has recorded details of Norwegian cattle since the 1960s, providing decades of breeding data. Geno also uses gene sequencing to determine breeding animals’ genetic composition; the page says its genetic and semen products have accuracy and reliability values for more than 90 health, yield, fertility, growth and feed-efficiency traits.
- The page links rising livestock production to population growth, higher incomes and dietary change. It cites OECD projections of 1% annual per-capita growth in global fresh-dairy consumption during 2020–2029 and global milk production reaching 997 metric tons by 2029. It identifies animal welfare, antibiotics and dairy emissions as sustainability challenges that healthier, more productive cattle can help address.
- Reported benefits include lower disease susceptibility and antibiotic use; improved feed efficiency and yield; lower cost and environmental footprint per unit of dairy; dual-purpose production of milk and meat; and longer productive lifespans compared with most modern dairy breeds. The article says Norway has one of the world’s lowest livestock antibiotic-use rates.
- The page cites a forecast that the global animal-genetics-products market would reach about USD 7 billion by 2026. Geno says it serves farmers worldwide, with strong presence in the UK and US and significant exports to Asia, mainland Europe and South America. It identifies Geno as a member of NCE Heidner Biocluster. SDGs shown: 2 and 12.
- Contact: Els Olsen, Marketing & Communications Specialist, els.olsen@geno.no; phone-number reveal control is present but collapsed. Company: GENO SA, Storhamargata 44, 2317 Hamar, Norway; norwegianred.com.